COVID survivors wanted for landmark Long-Term health study
NCT ID NCT04527315
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study follows 1500 adults who had COVID-19 to see how the virus affects their heart and lungs over time. Researchers will track inflammation markers and breathing problems using questionnaires. The goal is to learn more about recovery, not to test a treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 1,500 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jul 2020
- Expected to finish
-
Dec 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Patients who have had a positive COVID-19 test, but were not hospitalized/admitted will also be identified and eligible to participate in the study. Age and sex matched controls will also be recruited from those with no clinical history of COVID-19.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * have tested positive for SARS-CoV-2 and discharged from the ICU or, * have tested positive for SARS-CoV-2 and have been discharged from hospital or, * have tested positive for SARS-CoV-2 but was NOT hospitalized * ages 18 and over, and * competent and willing to sign informed consent and comply to all aspects of the protocol CONTROL Inclusion Criteria * No clinical history of COVID-19, * No active clinical symptoms indicative of possible COVID-19, * Ages 18 and over, * competent and willing to sign informed consent and comply to all aspects of the protocol Exclusion Criteria: • Participants cannot sign consent Any individual who meets any of the following criteria will be excluded from participation to the MRI or x-ray portion of the study: * Participants who are pregnant or currently trying to get pregnant * Participants unable to comply with any portion of the protocol (i.e. removing metals prior to entering the MRI scan room) or who have contraindications to MRI scanning (i.e., non-MRI-conditional pacemakers/defibrillators, pregnancy, ferromagnetic implants such as aneurysm clips, surgical clips, prostheses, artificial hearts, valves with steel parts, metal fragments, shrapnel, tattoos near the eye, or steel implants) * Persistent symptoms related to COVID-19 (in which case the patient may be re-screened later) As is done for all patients undergoing clinical MRI in our department, each patient will be screened for contraindications to MRI with a routine questionnaire prior to scanning. CONTROL Exclusion Criteria Patients with any of the following are excluded from as controls: * Pace maker * Poorly controlled diabetes * Poorly controlled Restrictive lung disease * Heart failure * Parkinson's Disease * Hypertension * Any diagnosis or history of autonomic neuropathy
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID19 are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The study's own enquiry address
This study publishes an address for enquiries. See it below .
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Email: •••••@•••••
Locations
-
NYU Langone Health
RECRUITINGNew York, New York, 10016, United States
Contact Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Home antibody tests put to the test: can you read your own COVID-19 result?
- COVID-19's hidden toll: muscle wasting in the ICU
- Can a mild case of COVID-19 harm your kidneys? urine tests may hold the answer
- Could a common acne pill weaken the nose's defense against COVID-19?
- Could cystic fibrosis offer hidden protection against COVID-19?
- Could a different way of pedaling rebuild muscles after severe COVID-19?